EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma

Namrata Anand iD, Keng Hee Peh iD, Jill M Kolesar iD

International Journal of Molecular Sciences · 02.02.2023 · 24 (3) · 2858

DOI: 10.3390/ijms24032858 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.02.2023. Verfasst von Namrata Anand und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY 40508, USA. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kentucky Cabinet For Health and Family Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophages are versatile immune cells and can adapt to both external stimuli and their surrounding environment. Macrophages are categorized into two major categories; M1 macrophages release pro-inflammatory cytokines and produce protective responses that lead to antimicrobial or antitumor activity. M2 or tumor-associated macrophages (TAM) release anti-inflammatory cytokines that support tumor growth, invasion capacity, and metastatic potential. Since macrophages can be re-polarized from an M2 to an M1 phenotype with a variety of strategies, this has emerged as an innovative anti-cancer approach. Osteosarcoma (OS) is a kind of bone cancer and consists of a complex niche, and immunotherapy is not very effective. Therefore, immediate attention to new strategies is required. We incorporated the recent studies that have used M2-M1 repolarization strategies in the aspect of treating OS cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsHumansMacrophagesCytokinesImmunotherapy

Stichwörter der Autor:innen

M1 macrophageM2 macrophageTAMTMEosteosarcomapolarizationrepolarization

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY 40508, USA.
  • Markey Cancer Center, University of Kentucky, Lexington, KY 40508, USA.

ORCID-Profile: Namrata Anand, Keng Hee Peh, Jill M Kolesar

Förderung

  • Kentucky Cabinet For Health and Family Services

Zitieren

APA

Anand, N., Peh, K. H., & Kolesar, J. M. (2023). Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma. International Journal of Molecular Sciences, 24(3), 2858. https://doi.org/10.3390/ijms24032858

Vancouver

Anand N, Peh KH, Kolesar JM. Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma. International Journal of Molecular Sciences. 2023;24(3):2858. doi:10.3390/ijms24032858

BibTeX
@article{Anand2023,
  author = {Anand, Namrata and Peh, Keng Hee and Kolesar, Jill M},
  title = {Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2858},
  doi = {10.3390/ijms24032858}
}
Kostenlos starten →